Rapid Dose Therapeutics Corp. (CSE: DOSE)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020
Market Capitalization	24	21	9	26	17	27
Market Cap Growth	33.23%	121.17%	-64.76%	56.16%	-36.29%	-57.36%
Enterprise Value	27	23	11	28	18	28
Last Close Price	0.19	0.17	0.09	0.26	0.21	0.34
PS Ratio	14.87	20.20	12.98	15.10	22.43	261.96
PB Ratio	-5.14	-6.53	-3.49	105.16	-15.55	-179.91
P/TBV Ratio	-	-	-	105.16	-	-
EV/Sales Ratio	20.08	23.00	15.75	15.81	24.39	273.86
Debt / Equity Ratio	-0.69	-0.78	-0.80	5.69	-2.01	-9.15
Asset Turnover	0.70	0.49	0.27	0.51	0.19	0.02
Inventory Turnover	2.56	2.79	1.66	1.26	0.43	0.37
Quick Ratio	0.10	0.13	0.04	0.09	0.08	0.03
Current Ratio	0.21	0.23	0.09	0.25	0.19	0.12
Return on Equity (ROE)	-	-	-	-	-	-432.88%
Return on Assets (ROA)	-130.88%	-93.10%	-83.34%	-77.93%	-25.16%	-93.14%
Return on Capital (ROIC)	-	-	-389.55%	-193.25%	-88.74%	-186.45%
Earnings Yield	-26.91%	-20.89%	-40.87%	-32.08%	-10.66%	-29.96%
FCF Yield	-14.14%	-11.13%	-9.27%	-11.49%	-9.64%	-16.01%
Buyback Yield / Dilution	7.40%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%
Total Shareholder Return	7.40%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%

Source: S&P Capital IQ. Standard template. Financial Sources.